| 000 | 01589 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516002422.0 | ||
| 264 | 0 | _c20110629 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.2010.01025.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAble, S L | |
| 245 | 0 | 0 |
_aReceptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJan 2011 |
||
| 300 |
_a405-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aGuanidines _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPurinergic P2X Receptor Antagonists _xmetabolism |
| 650 | 0 | 4 |
_aQuinolines _xblood |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2X7 _xmetabolism |
| 650 | 0 | 4 |
_aSpinal Cord _xmetabolism |
| 700 | 1 | _aFish, R L | |
| 700 | 1 | _aBye, H | |
| 700 | 1 | _aBooth, L | |
| 700 | 1 | _aLogan, Y R | |
| 700 | 1 | _aNathaniel, C | |
| 700 | 1 | _aHayter, P | |
| 700 | 1 | _aKatugampola, S D | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 162 _gno. 2 _gp. 405-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2010.01025.x _zAvailable from publisher's website |
| 999 |
_c20171301 _d20171301 |
||